Bayer: ‘Mirena training workshop’ weblink found misleading (EvoInserter training expectation) — AUTH/2579/2/13

📅 2013 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2579/2/13
ComplainantGeneral practitioner
CompanyBayer
ProductMirena (levonorgestrel intrauterine system) / EvoInserter insertion device
Issue“Mirena training workshop” weblink used to access all Mirena meetings, creating misleading expectation of EvoInserter training
Complaint received20 February 2013
Case completed28 March 2013
Applicable Code year2012
Breach clausesClause 7.2
No breach clausesClauses 12.1, 9.1
SanctionUndertaking received
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A GP complained he was misled into attending a meeting he believed would provide hands-on training to fit Mirena using the new EvoInserter insertion device.
  • The Mirena online training material said users could familiarise themselves with EvoInserter technique via an online module and/or by attending a “Mirena training workshop”, accessed via a “Mirena training workshop” link.
  • Bayer ran EvoInserter workshops in May–June 2012 (pre-launch) and removed dates from the website as each workshop occurred.
  • However, Bayer used the same “Mirena training workshop” link as the access point for all Mirena meetings throughout the year, even when the meeting title/content changed (eg, later “Mirena Medical Education Programme” meetings).
  • The complainant received logistics emails and an agenda for the Leicester meeting showing presentations on contraception and a counselling workshop (not practical EvoInserter training).
  • Bayer said the agenda was sent multiple times and that at the meeting there was a promotional stand where employees could demonstrate EvoInserter; demonstrator devices and models were available for practice.
⚖️

Outcome

  • Breach of Clause 7.2 (misleading) in relation to the website link arrangements.
  • No breach of Clause 12.1 (disguised promotion) regarding the meeting invitation/agenda.
  • No breach of Clause 9.1 (high standards).
  • Sanction: Undertaking received.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training